Previous Nav
Net Change on 01-08-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Divis Laboratories Ltd.
Cipla Ltd.
Lupin Ltd.
Glenmark Pharmaceuticals Ltd.
Ipca Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
Krishna Institute Of Medical Sciences Limited
Eris Lifesciences Ltd
Aster DM Healthcare Limited
Alkem Laboratories Ltd.
Gland Pharma Ltd.
Max Healthcare Institute Limited
Wockhardt Ltd.
TREPS - Tri-party Repo
Vijaya Diagnostic Centre Limited
Metropolis Healthcare Ltd.
Cohance Lifesciences Limited
Acutaas Chemicals Limited
Piramal Pharma Limited
Aurobindo Pharma Ltd.
Dr. Lal Path Labs Ltd
Jubilant Pharmova Limited
Fortis Healthcare Limited
Sai Life Sciences Limited
Pfizer Ltd.
Laxmi Dental Limited
BAJAJ HEALTHCARE LIMITED - Prefential Issue
Laurus Labs Ltd.
Medi Assist Healthcare Services Limited
Net Current Assets
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Medical Equipment/Supplies/Accessories
Business Support
Cash
Equity
HDFC Pharma and Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to HDFC Mutual Fund. It was launched on 04-Oct-2023 and currently has an AUM of ₹1,786.18 crore. HDFC Pharma and Healthcare Fund is benchmarked against BSE Health Care - TRI as primary index and NIFTY 50 - TRI as secondary index.
The NAV of HDFC Pharma and Healthcare Fund ended down ₹-0.41(-2.32%)yesterday to ₹17.292.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The HDFC Pharma and Healthcare Fund is managed by Nikhil Mathur .
HDFC House, 2nd floor, H.T. Parekh Marg, 165-166 Backbay Reclamation, Churchgate Mumbai - 400 020